Arginase-2 mediates diabetic renal injury. - Wikidata - wikimedia - TriplyDB

Arginase-2 mediates diabetic renal injury.

Arginase-2 mediates diabetic renal injury.

http://www.wikidata.org/entity/Q35405005

about

Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis Ventral prostate fibrosis in the Akita mouse is associated with macrophage and fibrocyte infiltration.Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice.Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy.Akita spontaneously type 1 diabetic mice exhibit elevated vascular arginase and impaired vascular endothelial and nitrergic function.Deletion of UNC5B in Kidney Epithelium Exacerbates Diabetic Nephropathy in Mice Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.Arginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic rats Arginase inhibition alleviates hypertension in the metabolic syndrome.Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS.Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism Cinnamide Derivatives as Mammalian Arginase Inhibitors: Synthesis, Biological Evaluation and Molecular Docking.l-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice.Genetic Targeting of Arginase-II in Mouse Prevents Renal Oxidative Stress and Inflammation in Diet-Induced Obesity.Macrophages directly mediate diabetic renal injury.Tubular injury marker netrin-1 is elevated early in experimental diabetes Critical role for arginase 2 in obesity-associated pancreatic cancer.Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.The Protective Effect of L-arginine in Cisplatin-induced Nephrotoxicity in Streptozotocin-induced Diabetic Rats.Nephron-Specific Deletion of Circadian Clock Gene Bmal1 Alters the Plasma and Renal Metabolome and Impairs Drug Disposition L-Arginine Supplementation in Type II Diabetic Rats Preserves Renal Function and Improves Insulin Sensitivity by Altering the Nitric Oxide Pathway.The subcellular compartmentalization of arginine metabolizing enzymes and their role in endothelial dysfunction.Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.Increased susceptibility to structural acute kidney injury in a mouse model of presymptomatic cardiomyopathy.Arginase-2 mediates renal ischemia-reperfusion injury.Distinct roles of arginases 1 and 2 in diabetic nephropathy.Metabolites associate with kidney function decline and incident chronic kidney disease in the general population.Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.Poly(ADP-ribose) polymerase 1 deficiency increases nitric oxide production and attenuates aortic atherogenesis through downregulation of arginase II.Disruption of renal arginine metabolism promotes kidney injury in hepatorenal syndrome.Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.Xiao-Shen-Formula, a Traditional Chinese Medicine, Improves Glomerular Hyper-Filtration in Diabetic Nephropathy via Inhibiting Arginase Activation and Heparanase Expression

P2860

Q33569387-26C6DB1B-EA3F-4C8A-B017-C4AA9B45398E Q33820772-2D318426-B33F-42F3-A7E7-6DBA1C044A8A Q34587701-ACC854A1-F6CB-4400-A007-70C3E29CC5A4 Q34627559-16D63FAB-1638-4DC5-BE1F-E816999A4177 Q34634938-30F948EE-C99C-4A9A-A313-07B1EE9AAC41 Q34973749-95BE8D21-ACC0-41AA-A726-40F05A9671CB Q35638934-4ED7D595-0674-461A-957D-C2D61C4DEB9A Q35710293-ED72BEFA-7811-4B91-A701-552280E9E87C Q36017619-05138B7B-072C-4600-BE28-E53C37C24320 Q36195357-66B3D779-0E47-4A52-A0C5-A6B907A1947B Q36787307-D798CE19-7D5B-40BB-9DF6-F6E28D6CBB07 Q36854784-8AD3ACAF-814A-44F5-BB83-F88E9120B9EC Q36929472-1E510BED-9A94-4E80-9FEB-DF29C280EFCB Q37102697-B507ABBA-B1AE-4F57-9E15-F0B934B30AC4 Q37142636-2048DC47-16B6-413F-BE42-C87EF804625D Q37142734-1E337DBA-68F6-4029-912A-BD158B923A75 Q37198831-215BF8E1-822A-4B6D-B6B4-694DF4ECB102 Q37377312-25E04CCD-2CC3-4483-8970-5145015D5F8E Q37412089-4479DFBD-55D7-431F-A289-E5F55A8ABECF Q37428427-6FA0349F-8D27-4D65-AEB0-60A3CF0DE74D Q37440181-C9FEF27A-3A9C-4955-B0AC-303FF2DCD2AB Q37727065-EB3B1DE2-9EAB-4EDA-A230-62D0ACF66AB6 Q41388458-97A67227-4BC8-45F4-83D1-9DB85BD75331 Q41559116-D9D7AB8A-A04E-4124-B820-0D2A41437057 Q41608850-496633F4-E51C-4D82-AFD3-7CD8CA4EF70E Q41645452-ECE81E3D-AB74-4A43-8D85-17A92681C97E Q41774748-210897AA-53A1-458C-94B4-8A54D62C1A4B Q43101543-CAE30BFE-15ED-49B3-AD80-495D8F047365 Q45232179-1524A051-FECF-4A71-AF6B-7D31D988EC29 Q47985501-CEE34360-BE62-4A3A-99DC-D9DA939F9DF8 Q50544634-E4550DFE-A6AF-4243-8E91-2DB33AAE2F24 Q50996032-F7903742-EA9C-42AE-9244-0E8AC9AFC5A3 Q51033386-E2F86FAD-F28E-4725-AAEE-28AE3E57146C Q51216532-453AB51C-F2C7-42AD-AABF-7B9856F987C8 Q51287276-BE89BEC5-4A7E-44BF-A9CC-96BDD6FED59D Q51376719-A6C44C1B-9147-45A9-92A8-F4EE1EA1D34C Q52598376-2B230087-1BA5-4A70-9506-F1F752DA3D86 Q53064414-DB9302C0-8B3B-40BC-819A-2F9B5D248FC6 Q57491629-DD652170-E348-4ED8-BD52-AF9AAC0A0362

P2860

Arginase-2 mediates diabetic renal injury.

http://www.wikidata.org/entity/Q35405005

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Arginase-2 mediates diabetic renal injury.

@ast

Arginase-2 mediates diabetic renal injury.

@en

type

label

Arginase-2 mediates diabetic renal injury.

@ast

Arginase-2 mediates diabetic renal injury.

@en

prefLabel

Arginase-2 mediates diabetic renal injury.

@ast

Arginase-2 mediates diabetic renal injury.

@en

P1433

Q35405005-5D929A33-44A8-473A-9840-23B5247F62F9

P1476

Q35405005-D6D6C8F1-A812-4218-A62E-5B9A00EEF69A

P2093

Q35405005-4CDAE543-DD80-4902-B8DF-4AAAD547A8B2

Q35405005-4F91DD55-1E83-46E7-8DCA-C7810F3AB50F

Q35405005-60004253-714C-44BC-927B-47A37AEA969F

Q35405005-A2EFF616-EE1A-4BCF-9839-6D6F058DCA9C

Q35405005-D906FD9F-D4D3-449F-AF36-07B70A461A69

P2860

Q35405005-081EFE61-54EE-42BA-A3F0-66FE42782B08

Q35405005-16B464C2-1506-44E6-BFAD-6B421F09D111

Q35405005-1F3DA2F1-73B5-4C6C-9C55-8DB8455E6579

Q35405005-33BCC2EE-2595-4E3B-AC0F-2C98E3472550

Q35405005-355FC9F5-77A7-4096-8FA6-4CD78A0803B8

Q35405005-391465F9-247E-44A6-8CC9-A23CFA109042

Q35405005-3BBD7221-5C1D-41CE-A381-87BACA577EE9

Q35405005-481EF3E0-A0FF-440D-A5FC-7C51CACB4415

Q35405005-4871C104-9BF2-4B7A-91C0-F31BD3626B5A

Q35405005-4AEF1B99-645F-4881-A055-7755F3A8E9ED

P304

Q35405005-B4DE6767-34BF-4C47-95A2-E7BA08C6F813

P31

Q35405005-9FA3E6ED-7C90-47D0-81D8-C562ADDD7A01

P356

Q35405005-904D69D6-9C62-46C4-99AA-FDD1EA5A0978

P407

Q35405005-8E8E206D-4078-4DF8-B59D-2A47F634FF3D

P433

Q35405005-D0C5FADC-81E0-43A2-9C7F-1402BFD2A44A

P478

Q35405005-37A3A122-4A7F-4451-8E97-12BD5836FDC1

P577

Q35405005-D42B6D4A-AF14-4AC7-82F8-E8562C753758

P5875

Q35405005-418588F8-24FD-481B-B4C8-E0490E5C5BCB

P698

Q35405005-4D95FC30-149C-4039-A897-62CCC57EFC47

P932

Q35405005-E5422B68-61A7-4C91-864A-AB113BB447BC

P356

P1433

P1476

Arginase-2 mediates diabetic renal injury.

@en

P2093

Alaa S Awad

http://www.w3.org/2001/XMLSchema#string

Diane Kepka-Lenhart

http://www.w3.org/2001/XMLSchema#string

Sidney M Morris

http://www.w3.org/2001/XMLSchema#string

Timothy K Cooper

http://www.w3.org/2001/XMLSchema#string

Ting Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line

Arginine metabolism: nitric oxide and beyond

Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury.

Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.

Workshop: endothelial cell dysfunction leading to diabetic nephropathy : focus on nitric oxide.

Mouse models of diabetic nephropathy.

Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence.

A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy

Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes

Recent advances in arginine metabolism: roles and regulation of the arginases.

P304

3015-3022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB11-0901

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51650690

http://www.w3.org/2001/XMLSchema#string

P698

21926276

http://www.w3.org/2001/XMLSchema#string

P932

3198072

http://www.w3.org/2001/XMLSchema#string